PTP1B has gained much attention in recent years due to its ability to attenuate insulin signaling and it is currently regarded as a potential therapeutic target against metabolic syndrome, obesity and diabetes. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.